The University of Chicago Header Logo

Connection

Everett E. Vokes to National Cancer Institute (U.S.)

Back to Details
This is a "connection" page, showing publications Everett E. Vokes has written about National Cancer Institute (U.S.).
Everett E. Vokes
Connection Strength
0.023
National Cancer Institute (U.S.)
  1. Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097). J Thorac Oncol. 2010 Aug; 5(8):1279-84.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.